Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention

NCT05764993 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COPD Exacerbation Acute

Interventions

BIOLOGICAL: CUVITRU - Ig subcutaneous human 20%
OTHER: Standard Medical Therapy

Sponsor

Rochester General Hospital

Collaborators

[object Object]